Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Transcriptional profiling of the bladder in urogenital schistosomiasis reveals pathways of inflammatory fibrosis and urothelial compromise.

Ray D, Nelson TA, Fu CL, Patel S, Gong DN, Odegaard JI, Hsieh MH.

PLoS Negl Trop Dis. 2012;6(11):e1912. doi: 10.1371/journal.pntd.0001912. Epub 2012 Nov 29.

2.

Controversies and challenges in research on urogenital schistosomiasis-associated bladder cancer.

Honeycutt J, Hammam O, Fu CL, Hsieh MH.

Trends Parasitol. 2014 Jul;30(7):324-32. doi: 10.1016/j.pt.2014.05.004. Epub 2014 Jun 6. Review.

3.

New research tools for urogenital schistosomiasis.

Rinaldi G, Young ND, Honeycutt JD, Brindley PJ, Gasser RB, Hsieh MH.

J Infect Dis. 2015 Mar 15;211(6):861-9. doi: 10.1093/infdis/jiu527. Epub 2014 Sep 19. Review.

4.

Immune responses to Schistosoma haematobium infection.

Odegaard JI, Hsieh MH.

Parasite Immunol. 2014 Sep;36(9):428-38. doi: 10.1111/pim.12084. Review.

5.

Assessment of morbidity in Schistosoma haematobium infection: current methods and future tools.

Jyding Vennervald B, Kahama AI, Reimert CM.

Acta Trop. 2000 Oct 23;77(1):81-9. Review.

PMID:
10996123
6.

Prostate adenocarcinoma associated with prostatic infection due to Schistosoma haematobium. Case report and systematic review.

Figueiredo JC, Richter J, Borja N, Balaca A, Costa S, Belo S, Grácio MA.

Parasitol Res. 2015 Feb;114(2):351-8. doi: 10.1007/s00436-014-4250-9. Epub 2014 Dec 30. Review.

PMID:
25544700
7.

Schistosomiasis: host-pathogen biology.

Warren KS.

Rev Infect Dis. 1982 Jul-Aug;4(4):771-5. Review.

PMID:
6750744
8.

Targeting molecular signaling pathways of Schistosoma haemotobium infection in bladder cancer.

Botelho MC, Machado JC, Brindley PJ, Correia da Costa JM.

Virulence. 2011 Jul-Aug;2(4):267-79. Epub 2011 Jul 1. Review.

PMID:
21788729
Items per page

Supplemental Content

Write to the Help Desk